Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06358001 · ClinicalTrials.gov registry record
EchoTip AcuCore Post-Market Clinical Study
A clinical trial of Hepatocellular Carcinoma and Cholangiocarcinoma, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- 183
- Enrollment target
- 8
- Study locations
NCT06358001: Completed study of Hepatocellular Carcinoma and Cholangiocarcinoma, sponsored by Cook Research Incorporated.
NCT06358001 is a study of Hepatocellular Carcinoma and Cholangiocarcinoma that has completed, run by Cook Research Incorporated. The registered enrollment target is 183 participants, below the 256-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (29% lower). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06358001, a study of Hepatocellular Carcinoma and Cholangiocarcinoma, has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- 183 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of collecting this data is to continue to learn more about the EchoTip AcuCore and the device's ability to produce the desired favorable effect and if there are any undesired outcomes that may be related to the EchoTip AcuCore.
Primary Outcome
The ability to obtain a sample without failure of the needle system necessitating the use of a new needle to complete the procedure
Conditions Studied
Interventions
- DEVICE EchoTip AcuCore
Study Locations (8)
Florida
- Shands Hospital-University of Florida - Gainesville
- University of Florida Shands Hospital - Gainesville
- Advent Health Medical Group, Orlando - Orlando
California
- University of California, Irvine - Orange
Colorado
- Advent Health, Porter - Denver
Pennsylvania
- Geisinger Medical Center - Danville
Texas
- University of Texas Memorial Hermann Hospital - Houston
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2024-08-05 |
| Est. Completion | 2025-07-19 |
What the finished NCT06358001 record still lists
NCT06358001 is an observational study that tracks outcomes without assigning an intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap, below the 256-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (29% lower).
The record links to 8 conditions, with Hepatocellular Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which EchoTip AcuCore is the first listed.
NCT06358001 lists 8 locations in 6 states (Florida, California, Colorado).
Frequently Asked Questions
What is clinical trial NCT06358001 about?
NCT06358001 is a clinical study titled "EchoTip AcuCore Post-Market Clinical Study". The purpose of collecting this data is to continue to learn more about the EchoTip AcuCore and the device's ability to produce the desired favorable effect and if there are any undesired outcomes that may be related to the EchoTip AcuCore.
What is the current status of trial NCT06358001?
This trial is currently completed. The enrollment target is 183 participants. The study started on 2024-08-05. Estimated completion is 2025-07-19.
What conditions does trial NCT06358001 study?
This clinical trial studies the following conditions: Hepatocellular Carcinoma, Cholangiocarcinoma, Neuroendocrine Tumors, Chronic Pancreatitis, Adenocarcinoma.
What interventions are being tested in trial NCT06358001?
The interventions under investigation include: EchoTip AcuCore (DEVICE).
Who is sponsoring clinical trial NCT06358001?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06358001 being conducted?
This trial has 8 study locations across California, Colorado, Florida, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatocellular Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06358001's enrollment target sits among peer trials
183 44th of 145 higher than 102 of 145 other Hepatocellular Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatocellular Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Molecular Basis of Pediatric Liver Cancer
RECRUITING
-
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RECRUITING · Phase 2
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Targeted Navigation in Hepatocellular Carcinoma (HCC)
RECRUITING · NA
-
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RECRUITING · Phase 1
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03859297 · 183 participants · NA
Mechanisms of Rumination Change in Adolescent Depression
- NCT04270591 · 183 participants · Phase 1
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- NCT06764615 · 183 participants · Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- NCT06872684 · 183 participants · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI